98%
921
2 minutes
20
The pathological microenvironment following peripheral nerve injury (PNI) comprises a dynamic interplay of cellular and molecular events that critically influence neuronal regeneration and functional recovery. Recent advances in nanotechnology have demonstrated the transformative potential of nanomaterials (NMs) in nerve repair, capitalizing on their unique physicochemical properties to engineer a pro-regenerative milieu that facilitates axonal regrowth. This review systematically explores the biological mechanisms by which NMs modulate and remodel the injury niche, thereby enhancing peripheral nerve regeneration (PNR). Specifically, this review highlights five key microenvironmental regulators, including rebuilding remyelinating Schwann cells, balancing the immune microenvironment, forming blood vessels, constructing extracellular matrix, and regulating cytokines and hormones. By analyzing these NMs-mediated therapeutic strategies, we provide novel mechanistic insights and discuss translational opportunities for next-generation nanomedicine in PNR therapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12124646 | PMC |
http://dx.doi.org/10.1016/j.mtbio.2025.101808 | DOI Listing |
Sci Transl Med
September 2025
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
Oligodendrocytes, the myelinating cells of the central nervous system (CNS), are essential for the formation of myelin sheaths and pivotal for maintaining axonal integrity and conduction. Disruption of these cells and the myelin sheaths they produce is a hallmark of demyelinating conditions like multiple sclerosis or those resulting from certain drug side effects, leading to profound neurological impairments. In this study, we created a human brain organoid comprising neurons, astrocytes, and myelinating oligodendrocytes.
View Article and Find Full Text PDFIEEE Trans Neural Syst Rehabil Eng
September 2025
Unilateral facial palsy, a common type of facial paralysis, profoundly impacts individuals' daily functionality and quality of life. The current clinical diagnosis of facial paralysis primarily relies on the subjective judgment of doctors, and the development of automated detection methods is challenged by the lack of publicly available facial paralysis datasets and the inability to analyze different facial nerve branches. To address these problems, we propose a new benchmark named UPFG-SG for Unilateral Peripheral Facial Paralysis Severity Grading.
View Article and Find Full Text PDFClin Orthop Relat Res
September 2025
Leni & Peter W. May Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Background: Peripheral nerve injury commonly results in pain and long-term disability for patients. Recovery after in-continuity stretch or crush injury remains inherently unpredictable. However, surgical intervention yields the most favorable outcomes when performed shortly after injury.
View Article and Find Full Text PDFChilds Nerv Syst
September 2025
Department of Orthopedics, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Objective: To analyze the filum terminale (FT) of children with tethered cord syndrome (TCS) and aborted fetuses without neurological disorders in order to investigate the expression of significantly differentially expressed proteins in the FT under both pathological and physiological conditions.
Methods: According to the inclusion and exclusion criteria, 35 FT samples were selected, and the samples were subjected to immunohistochemistry and H&E staining. The data were analyzed using one-way analysis of variance, and P < 0.
Invest Ophthalmol Vis Sci
September 2025
Department of Optometry and Vision Sciences, The University of Melbourne, Melbourne, Australia.
Purpose: To characterize corneal immune cell morphodynamics and nerve features, and define the in vivo immune landscape in older adults with human immunodeficiency virus (HIV) receiving antiretroviral therapy (ART), relative to healthy age-matched adults.
Methods: In this cross-sectional study, 16 HIV-positive individuals receiving ART and 15 age-matched controls underwent ocular surface examinations and functional in vivo confocal microscopy (Fun-IVCM). Time-lapsed videos were created to analyze corneal immune cells (T cells, dendritic cells [DCs], macrophages).